Larry Borish Selected Research

Common Variable Immunodeficiency

1/2018

Low Serum IgE Is a Sensitive and Specific Marker for Common Variable Immunodeficiency (CVID).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Larry Borish Research Topics

Disease

42	Asthma (Bronchial Asthma) 05/2023 - 12/2002
30	Inflammation (Inflammations) 05/2024 - 04/2002
16	Hypersensitivity (Allergy) 01/2022 - 06/2004
16	Rhinosinusitis 01/2022 - 12/2002
14	Nasal Polyps (Nasal Polyp) 01/2022 - 11/2006
14	Sinusitis 10/2013 - 04/2002
12	Eosinophilia 01/2021 - 02/2003
11	Infections 05/2024 - 09/2014
8	Allergic Rhinitis 11/2020 - 04/2002
7	Rhinitis 01/2021 - 12/2003
6	Polyps 01/2022 - 03/2007
5	Anaphylaxis (Anaphylactic Shock) 10/2020 - 06/2004
5	Fibrosis (Cirrhosis) 10/2011 - 06/2005
3	Agammaglobulinemia (Hypogammaglobulinemia) 04/2024 - 08/2015
3	Reinfection 01/2023 - 01/2018
3	Immediate Hypersensitivity 01/2021 - 05/2013
3	Allergic Fungal Sinusitis 07/2016 - 11/2006
3	Hypoxia (Hypoxemia) 11/2008 - 03/2007
3	Bronchial Spasm 05/2008 - 05/2004
2	Cystic Fibrosis (Mucoviscidosis) 05/2023 - 01/2020
2	Primary Immunodeficiency Diseases 01/2023 - 01/2022
2	COVID-19 10/2022 - 01/2022
2	Chronic Urticaria 07/2018 - 07/2010
2	Hyperplasia 11/2017 - 06/2005
2	Anosmia 11/2016 - 07/2016
2	Respiratory Hypersensitivity 01/2013 - 03/2002
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Emphysema 01/2023
1	Breakthrough Infections 10/2022
1	Bronchial Hyperreactivity 01/2022
1	Human Influenza (Influenza) 01/2022
1	Gastroesophageal Reflux (GERD) 01/2021
1	Disease Progression 01/2020
1	Drug Hypersensitivity (Drug Allergy) 11/2019

Drug/Important Bio-Agent (IBA)

28	Immunoglobulin E (IgE)IBA 05/2024 - 03/2003
15	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 11/2004
13	CytokinesIBA 01/2021 - 03/2002
12	AllergensIBA 01/2023 - 03/2002
12	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 12/2003
11	LeukotrienesIBA 01/2021 - 04/2002
6	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2015
6	InterleukinsIBA 01/2023 - 02/2004
6	Interleukin-5 (Interleukin 5)IBA 01/2023 - 03/2002
5	AntigensIBA 05/2023 - 03/2002
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2023 - 11/2013
4	Interleukin-4 (Interleukin 4)IBA 01/2023 - 04/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2007
4	anti-IgE antibodiesIBA 01/2021 - 05/2013
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 02/2008
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 06/2005
3	Antiviral Agents (Antivirals)IBA 01/2022 - 05/2008
3	SteroidsIBA 12/2017 - 11/2005
3	2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA 09/2013 - 06/2006
3	Interleukin-33IBA 01/2013 - 02/2011
3	AntibodiesIBA 07/2010 - 02/2006
2	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 12/2010
2	Polysaccharides (Glycans)IBA 01/2023 - 11/2022
2	Monoclonal AntibodiesIBA 01/2023 - 01/2015
2	Interleukin-5 Receptors (Interleukin 5 Receptor)IBA 01/2023 - 01/2021
2	Neutralizing AntibodiesIBA 10/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 10/2022 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2020
2	ChemokinesIBA 01/2021 - 05/2004
2	Interleukin-13IBA 11/2020 - 04/2010
2	RNA (Ribonucleic Acid)IBA 10/2020 - 10/2011
2	mepolizumabIBA 01/2020 - 01/2015
2	Omalizumab (Xolair)FDA Link 01/2020 - 07/2018
2	Chemotactic FactorsIBA 01/2019 - 01/2019
2	AutoantibodiesIBA 09/2014 - 07/2010
2	SuperantigensIBA 11/2013 - 09/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2013 - 09/2004
2	cysteinyl-leukotrieneIBA 10/2009 - 02/2003
2	Oxygen (Dioxygen)IBA 02/2008 - 03/2007
2	Leukotriene C4IBA 09/2006 - 11/2004
1	C-Reactive ProteinIBA 05/2024
1	ivacaftor drug combination tezacaftorIBA 05/2023
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 05/2023
1	Immunologic Factors (Immunomodulators)IBA 05/2023
1	elexacaftorIBA 05/2023
1	dupilumabIBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 11/2022
1	COVID-19 VaccinesIBA 10/2022
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2022
1	Crotalidae Polyvalent immune FabIBA 01/2021
1	Thymic Stromal LymphopoietinIBA 01/2021
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2021
1	Antivenins (Antivenoms)IBA 01/2021
1	EnzymesIBA 01/2021
1	LipidsIBA 01/2021
1	Prostaglandin D2IBA 01/2021
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 10/2020
1	Indicators and Reagents (Reagents)IBA 10/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	Dinoprostone (PGE2)FDA Link 11/2019
1	Prednisone (Sone)FDA LinkGeneric 07/2019
1	Leukotriene B4IBA 01/2019
1	leukotriene A4 hydrolaseIBA 01/2019
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2019

Therapy/Procedure

21	Therapeutics 05/2023 - 12/2003
7	Immunotherapy 01/2022 - 06/2004